This “series” of monthly podcasts will feature new information and emerging topics that are published as our Editor’s Choice article in the journal. The Podcasts will be hosted by one of the Journal’s editors and include a conversation with the author of the Editor’s choice article along with the author of the featured commentary/editorial that accompanies the lead article.
If you experience trouble listening to the podcasts, please download the mp3 file, right-click (on a PC) or control-click (on a Mac) and choose "Save Link As" to play on your computer.
Five Ways to Access the Podcasts:
- Open and download any of the individual files below.
- If you have the iTunes media player, you can subscribe to listen to Gynecologic Oncology Podcasts at the iTunes Music Store.
- If you have the Google media player, you can subscribe to listen to Gynecologic Oncology Podcasts via Google Podcasts.
- Listen and subscribe to the podcast via Spotify at https://open.spotify.com/show/1PSI1VIF5mS77NWgCcs6cl.
- For automatic delivery of content of each issue, copy and paste http://www.gynecologiconcology-online.net/pb/assets/raw/Health%20Advance/journals/ygyno/podcasts/ygyno_podcasts_rss.xml to your RSS reader.
Gynecologic Oncology Podcast on the Future of the Gyn Onc Subspecialty
In this new, Special Edition of the Gynecologic Oncology video podcast, The Future of Gynecologic Oncology: We are at a Crossroads, David E. Cohn, MD, MBA, President of the SGO and Deputy Editor of Gynecologic Oncology, and Warner K. Huh, MD, Immediate Past-President of the SGO, engage in a lively discussion about Dr. Huh’s vision for the SGO and gynecologic oncology as a subspecialty. Initially envisioned as part of Dr. Huh’s Presidential Address for the SGO 2020 Annual Meeting in Toronto, this podcast puts the events of the past year in perspective, while remaining focused on the long-term future of gynecologic oncology.
February 2023 Editor’s Choice: A Geo-Analyzer Tool that assessed insured patients in your metropolitan area with recurrent and metastatic cervix cancer
Wendy R. Brewster, MD, PhD, Deputy Editor of Gynecologic Oncology
Turgay Ayer, Georgia Institute of Technology
Tara Castellano, MD, Louisiana State University HSC
Isabel C. Scarinci, PhD, MPH, University of Alabama at Birmingham
Editor’s Choice Paper: Cervical cancer geographical burden analyzer: An interactive, open-access tool for understanding geographical disease burden in patients with recurrent or metastatic cervical cancer
Editorial: Targeting our efforts: the contribution of an open-access tool to assess geographic distribution of recurrent and metastatic cervical cancer
January 2023 Editor’s Choice: Sentinel lymph node mapping in endometrial complex atypical hyperplasia: good idea or have we gone too far?
Editor’s Choice Papers:
Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon?
Is sentinel lymph node assessment useful in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia?
Editorial: Routine SLN biopsy for endometrial intraepithelial neoplasia: A pragmatic approach or over-treatment?
Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology
Jennifer Mueller MD, Memorial Sloan Kettering Cancer Center
Emad Matanes MD, Rambam Medical Center
Emma Rossi MD, Duke University Medical Center
Molecular Testing for Endometrial Cancer: A Society of Gynecologic Oncology Podcast
Moderator: Kari Hacker, MD, PhD, Gynecologic Oncologist, New York University Langone Health
Christine Walsh, MD, MS, Gynecologic Oncologist, University of Colorado
Carolyn McCourt, MD, Gynecologic Oncologist, Washington University School of Medicine
Kari Hacker, MD, PhD, is joined by Christine Walsh, MD, MS, and Carolyn McCourt, MD, to review basic molecular classification as well as more complex biomarkers in endometrial cancer. They discuss how testing can be utilized to inform patient prognosis and to guide second line systemic treatment decisions. They also highlight several ongoing trials investigating treatment strategies based on molecular features, the results of which will help clinicians make better therapeutic decisions, resulting in better outcomes for patients with endometrial cancer. This podcast was developed by the Society of Gynecologic Oncology for Gynecologic Oncology.
Additional Resources: Molecular testing for endometrial cancer: An SGO clinical practice statement
Burnout and gynecologic oncology - does the problem still exist?
Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology
Brittany A. Davidson, MD, Duke University
David M. Kushner, MD, UW School of Medicine and Public Health
Article: SGO and the elephant that is still in the room: Wellness, burnout and gynecologic oncology
December 2022 Editor’s Choice: Exceptional PARP inhibitor responders: the good and the bad
Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology and Author of the editorial
Featuring: David O'Malley, MD, The Ohio State University
Editor’s Choice Paper: Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma
Editorial: The rapid evolution of PARP inhibitor therapy for advanced ovarian cancer: Lessons being learned and new questions emerging from phase 3 trial long-term outcome data